Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Healthcare ITIn Vitro DiagnosticsDrug DiscoveryArtificial IntelligenceAI Drug DiscoveryDiagnostics AI

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1785939

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1785939

Cardiac Artificial Intelligence Monitoring and Diagnostics

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market to Reach US$5.7 Billion by 2030

The global market for Cardiac Artificial Intelligence Monitoring and Diagnostics estimated at US$1.3 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. Cardiac AI Monitoring & Diagnostics Hardware, one of the segments analyzed in the report, is expected to record a 30.5% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Cardiac AI Monitoring & Diagnostics Software segment is estimated at 25.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$346.6 Million While China is Forecast to Grow at 25.9% CAGR

The Cardiac Artificial Intelligence Monitoring and Diagnostics market in the U.S. is estimated at US$346.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$850.4 Million by the year 2030 trailing a CAGR of 25.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.5% and 23.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.7% CAGR.

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market - Key Trends & Drivers Summarized

Why Is the Demand for Cardiac Artificial Intelligence Monitoring and Diagnostics Increasing?

The demand for cardiac artificial intelligence monitoring and diagnostics is rising due to the increasing prevalence of cardiovascular diseases, the need for early and accurate detection, and advancements in AI-driven healthcare solutions. Heart diseases, including coronary artery disease, heart failure, and arrhythmias, remain the leading cause of mortality worldwide. Traditional diagnostic methods, while effective, often require time-consuming interpretation and are prone to human error. AI-powered monitoring systems and diagnostic tools are transforming cardiovascular care by providing faster, more precise, and real-time insights into heart health.

The rise of wearable health technology, remote patient monitoring, and AI-assisted imaging has made cardiac diagnostics more accessible and proactive. AI-powered ECG interpretation, predictive analytics for heart failure, and automated detection of arrhythmias are helping clinicians make informed decisions while reducing the burden on healthcare providers. Additionally, the integration of AI in telehealth and digital health platforms allows for early intervention, particularly in high-risk patients, reducing hospitalizations and improving patient outcomes. As healthcare systems shift towards predictive and preventive cardiology, the adoption of AI-driven cardiac diagnostics is expected to expand.

How Are Technological Advancements Improving Cardiac AI Monitoring and Diagnostics?

Innovations in artificial intelligence, deep learning, and wearable sensor technology are enhancing the accuracy, efficiency, and accessibility of cardiac monitoring and diagnostics. One of the most significant advancements is the development of AI-enhanced electrocardiograms (ECGs) that can detect complex cardiac conditions such as atrial fibrillation, ventricular tachycardia, and myocardial infarctions with high accuracy. AI-powered ECG algorithms can analyze vast amounts of data in real-time, reducing diagnostic errors and improving early detection rates.

Another major breakthrough is the integration of AI in cardiovascular imaging, including echocardiography, cardiac MRI, and CT angiography. AI-driven imaging solutions assist radiologists and cardiologists in identifying abnormalities, quantifying heart function, and assessing coronary artery disease more efficiently. Additionally, wearable AI-powered cardiac monitors, such as smartwatches and biosensors, provide continuous, real-time heart health monitoring, alerting users and healthcare providers to potential risks before symptoms become critical. Machine learning models are also being developed to predict heart disease progression and personalize treatment plans based on patient-specific data. As AI technology continues to evolve, its role in cardiac care will become even more prominent, improving accuracy, efficiency, and early disease detection.

Which Market Trends Are Driving Growth in the Cardiac AI Monitoring and Diagnostics Industry?

The increasing adoption of AI in telemedicine and remote patient monitoring is one of the most influential trends shaping the cardiac artificial intelligence market. With the rise of virtual healthcare, AI-powered cardiac monitoring devices are enabling continuous, at-home heart health tracking, reducing the need for frequent hospital visits. This trend is particularly important for managing chronic heart conditions and high-risk patients, as real-time AI analytics can help detect irregularities before they lead to severe complications.

Another key trend influencing market growth is the expansion of AI in personalized medicine. AI-driven analytics are being used to tailor treatment plans based on individual patient data, improving outcomes for those with heart disease. Additionally, pharmaceutical companies are leveraging AI to optimize drug discovery for cardiovascular treatments, further integrating AI into the broader ecosystem of cardiac care. The rise of big data in cardiology, along with cloud-based AI solutions, is enabling seamless data sharing and real-time collaboration between healthcare professionals, enhancing patient care. As AI-driven diagnostics continue to improve, they are increasingly being integrated into hospital workflows, making AI-powered cardiac monitoring a standard in cardiovascular healthcare.

What Are the Key Growth Drivers Shaping the Future of the Cardiac AI Monitoring and Diagnostics Market?

The growth in the cardiac artificial intelligence monitoring and diagnostics market is driven by several key factors, including rising cardiovascular disease prevalence, advancements in AI algorithms, and the expansion of digital health infrastructure. One of the primary growth drivers is the increasing burden of heart disease, prompting the need for early detection, predictive analytics, and continuous monitoring solutions. AI-driven diagnostic tools reduce the time required for heart disease diagnosis, allowing for faster interventions and improved patient outcomes.

Another crucial driver shaping the market is the increasing regulatory approvals and adoption of AI-powered diagnostic solutions by healthcare institutions. Governments and regulatory bodies are recognizing the potential of AI in cardiology, leading to greater investments in AI research and digital healthcare policies. Additionally, the affordability and accessibility of AI-driven wearables, coupled with improved AI interpretability, are making cardiac monitoring more patient-friendly and scalable. As AI integration in healthcare continues to accelerate, the cardiac AI monitoring and diagnostics market is expected to witness substantial growth, revolutionizing heart disease detection, prevention, and management worldwide.

SCOPE OF STUDY:

The report analyzes the Cardiac Artificial Intelligence Monitoring and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Cardiac AI Monitoring and Diagnostics Hardware, Cardiac AI Monitoring and Diagnostics Software, Cardiac AI Monitoring and Diagnostics Services); Type (Cardiac Diagnostics, Cardiac Monitoring); Application (Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application, Stenosis Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP29823

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Artificial Intelligence Monitoring and Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cardiovascular Disease Burden Throws the Spotlight on AI-Powered Cardiac Monitoring Systems
    • Integration of AI in ECG, Imaging, and Wearables Propels Growth in Real-Time Diagnostic Capabilities
    • Early Detection and Risk Stratification Capabilities Expand the Addressable Market for AI Cardiac Tools
    • AI Algorithms for Arrhythmia, Heart Failure, and Ischemia Enhance Diagnostic Precision and Speed
    • Telecardiology Adoption Accelerates Demand for Remote AI-Driven Monitoring Platforms
    • Healthcare Shift Toward Predictive Analytics Strengthens the Business Case for AI Diagnostics
    • Wearable and Ambulatory Monitoring Devices Integrated with AI Spur Out-of-Hospital Cardiac Care Growth
    • Smart Hospitals and Digital Health Ecosystems Fuel Demand for AI-Based Clinical Decision Support Tools
    • AI-Powered Imaging Interpretation Drives Efficiency in Echocardiography and Cardiac MRI/CT Analysis
    • Regulatory Approvals of AI Software-as-Medical-Device (SaMD) Create New Commercial Pathways
    • Cardiology Workflow Optimization through AI Reduces Diagnostic Time and Clinical Burden
    • Collaborations Between MedTech and AI Startups Accelerate Product Innovation and Market Entry
    • Growing Role of AI in Population Health Management and Preventive Cardiology Supports Market Adoption
    • AI Model Transparency, Validation, and Explainability Become Critical in Regulatory and Clinical Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Artificial Intelligence Monitoring and Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiac Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Stroke Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ischemic Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Ischemic Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cardiac Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Cardiac Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Cardiac Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Cardiac Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • JAPAN
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CHINA
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • EUROPE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • FRANCE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • GERMANY
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!